BMO Capital Markets Boosts Bayer PT, Affirms at Market Perform

MT Newswires · 1d ago
09:00 AM EST, 11/04/2026 (MT Newswires) -- BMO Capital Markets on Tuesday increased its price target for pharmaceutical and biotechnology company Bayer (BAYN.F) to 56 euros from 49 euros, while maintaining a market perform rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)